Skip to main content
Top
Published in: BMC Pediatrics 1/2021

Open Access 01-12-2021 | Macrolide | Research article

Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia

Authors: Mingyu Tang, Dong Wang, Xing Tong, Yufen Wu, Jing Zhang, Lei Zhang, Yong Yin, Qing Cao

Published in: BMC Pediatrics | Issue 1/2021

Login to get access

Abstract

Background

Due to the lack of a sensitive, specific and rapid detection method, aetiological diagnosis of pneumonia caused by Mycoplasma pneumoniae (M. pneumoniae, MP) is a constantly challenging issue. This retrospective study aimed to compare the diagnostic methods for Mycoplasma pneumoniae in children and evaluate their values.

Methods

From November 2018 to June 2019, 830 children with community-acquired pneumonia were selected from the Department of Respiratory Medicine, Shanghai Children’s Medical Center. On the first day of hospitalization, sputum, throat swab and venous blood samples were collected to analyse MP-IgM (particle agglutination, PA), MP-IgM (immune colloidal gold technique, GICT), MP-DNA, MP-RNA (simultaneous amplification and testing, SAT) and MP-DNA (real-time polymerase chain reaction, RT-PCR).

Results

Among these 830 children, RT-PCR showed that the positive rate was 36.6% (304/830), in which the positive rate of macrolide resistance (A2063G mutation) accounted for 86.2% of cases (262/304). Using RT-PCR as the standard, MP-RNA (SAT) had the highest specificity (97.5%), and MP-IgM (PA) had the highest sensitivity (74.0%) and Youden index (53.7%). If MP-RNA (SAT) was combined with MP-IgM (PA), its Kappa value (0.602), sensitivity (84.2%), specificity (78.7%) and Youden index (62.9%) were higher than those of single M. pneumoniae detection.

Conclusions

Our research indicated that a combination of MP-RNA (SAT) plus MP-IgM (PA) might lead to reliable results as an early diagnostic method for children with clinical manifestations of Mycoplasma pneumoniae pneumonia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ken BW, Deborah FT. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728.CrossRef Ken BW, Deborah FT. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728.CrossRef
2.
go back to reference Hardy RD, Coalson JJ, Peters J, et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to mycoplasma pneumoniae CARDS toxin. PLoS One. 2009;4:e7562.CrossRef Hardy RD, Coalson JJ, Peters J, et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to mycoplasma pneumoniae CARDS toxin. PLoS One. 2009;4:e7562.CrossRef
3.
go back to reference Medina JL, Coalson JJ, Brooks EG, et al. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am J Respir Cell Mol Biol. 2012;46:815–22.CrossRef Medina JL, Coalson JJ, Brooks EG, et al. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am J Respir Cell Mol Biol. 2012;46:815–22.CrossRef
4.
go back to reference Medina JL, Coalson JJ, Brooks EG, et al. Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice. PLoS One. 2014;9:e102613.CrossRef Medina JL, Coalson JJ, Brooks EG, et al. Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice. PLoS One. 2014;9:e102613.CrossRef
5.
go back to reference Meyer Sauteur PM, van Rossum AM, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Curr Opin Infect Dis. 2014;27:220–7.CrossRef Meyer Sauteur PM, van Rossum AM, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Curr Opin Infect Dis. 2014;27:220–7.CrossRef
6.
go back to reference Zhang Y, Zhou Y, Li S, et al. The clinical characteristics and predictors of refractory mycoplasma pneumoniae pneumonia in children. PLoS One. 2016;11:e0156465.CrossRef Zhang Y, Zhou Y, Li S, et al. The clinical characteristics and predictors of refractory mycoplasma pneumoniae pneumonia in children. PLoS One. 2016;11:e0156465.CrossRef
7.
go back to reference Zhou Z, Li X, Chen X, et al. Macrolide-resistant mycoplasma pneumonia in adults in Zhejiang, China. Antimicrob Agents Chemother. 2015;59:1048–51.CrossRef Zhou Z, Li X, Chen X, et al. Macrolide-resistant mycoplasma pneumonia in adults in Zhejiang, China. Antimicrob Agents Chemother. 2015;59:1048–51.CrossRef
8.
go back to reference Principi N, Esposito S. Macrolide-resistant mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother. 2013;68:506–11.CrossRef Principi N, Esposito S. Macrolide-resistant mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother. 2013;68:506–11.CrossRef
9.
go back to reference Bebear C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011;6:423–31.CrossRef Bebear C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011;6:423–31.CrossRef
10.
go back to reference Fischer JE, Steiner F, Zucol F, et al. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia. Arch Pediatr Adolesc Med. 2002;156:1005–8.CrossRef Fischer JE, Steiner F, Zucol F, et al. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia. Arch Pediatr Adolesc Med. 2002;156:1005–8.CrossRef
11.
go back to reference Wang K, Gill P, Perera R, et al. Clinical symptoms and signs for the diagnosis of mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012;10:CD009175.PubMed Wang K, Gill P, Perera R, et al. Clinical symptoms and signs for the diagnosis of mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012;10:CD009175.PubMed
12.
go back to reference Waites KB, Li X, Yang L, et al. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017;30:747–809.CrossRef Waites KB, Li X, Yang L, et al. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017;30:747–809.CrossRef
13.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRef Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRef
14.
go back to reference Miyashita N, Kawai Y, Tanaka T, et al. Diagnostic sensitivity of a rapid antigen test for the detection of mycoplasma pneumoniae: comparison with real-time PCR. J Infect Chemother. 2015;21:473–5.CrossRef Miyashita N, Kawai Y, Tanaka T, et al. Diagnostic sensitivity of a rapid antigen test for the detection of mycoplasma pneumoniae: comparison with real-time PCR. J Infect Chemother. 2015;21:473–5.CrossRef
15.
go back to reference Maheshwari M, Kumar S, Sethi GR, et al. Detection of mycoplasma pneumoniae in children with lower respiratory tract infections. Trop Dr. 2011;41:40–2.CrossRef Maheshwari M, Kumar S, Sethi GR, et al. Detection of mycoplasma pneumoniae in children with lower respiratory tract infections. Trop Dr. 2011;41:40–2.CrossRef
16.
go back to reference Gadsby NJ, Reynolds AJ, McMenamin J, et al. Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011-Impact of the epidemic in infants. Euro Surveill. 2012;17:20110. Gadsby NJ, Reynolds AJ, McMenamin J, et al. Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011-Impact of the epidemic in infants. Euro Surveill. 2012;17:20110.
17.
go back to reference Seema J, Derek JW, Sandra RA, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835–45.CrossRef Seema J, Derek JW, Sandra RA, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835–45.CrossRef
18.
go back to reference Song M, Zhang Y, Li S, et al. A sensitive and rapid immunoassay for mycoplasma pneumoniae in children with pneumonia based on single-walled carbon nanotubes. SciRep. 2017;7:16442. Song M, Zhang Y, Li S, et al. A sensitive and rapid immunoassay for mycoplasma pneumoniae in children with pneumonia based on single-walled carbon nanotubes. SciRep. 2017;7:16442.
19.
go back to reference Carrim M, Wolter N, Benitez AJ, et al. Epidemiology and molecular identification and characterization of mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018;24:506–13.CrossRef Carrim M, Wolter N, Benitez AJ, et al. Epidemiology and molecular identification and characterization of mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018;24:506–13.CrossRef
20.
go back to reference Meyer Sauteur PM, Unger WWJ, Nadal D, et al. Infection with and carriage of mycoplasma pneumonia in children. Front Microbiol. 2016;7:329.CrossRef Meyer Sauteur PM, Unger WWJ, Nadal D, et al. Infection with and carriage of mycoplasma pneumonia in children. Front Microbiol. 2016;7:329.CrossRef
21.
go back to reference Li W, Liu Y, Yu Z, et al. Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay. Sci Rep. 2015;5:15539.CrossRef Li W, Liu Y, Yu Z, et al. Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay. Sci Rep. 2015;5:15539.CrossRef
22.
go back to reference Chong H, Peiting H, Jieying Y, et al. Pooled pooled analysis of nuclear acid sequence-based amplification for rapid diagnosis of mycoplasma Pneumoniae infection. J Clin Lab Anal. 2019;33:e22879. Chong H, Peiting H, Jieying Y, et al. Pooled pooled analysis of nuclear acid sequence-based amplification for rapid diagnosis of mycoplasma Pneumoniae infection. J Clin Lab Anal. 2019;33:e22879.
23.
go back to reference Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide- resistant mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624–30.CrossRef Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide- resistant mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624–30.CrossRef
24.
go back to reference Yang HJ, Song DJ, Shim JY, et al. Mechanism of resistance acquisition and treatment of macrolide-resistant mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2017;60:167–74.CrossRef Yang HJ, Song DJ, Shim JY, et al. Mechanism of resistance acquisition and treatment of macrolide-resistant mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2017;60:167–74.CrossRef
25.
go back to reference Liu X, Jiang Y, Chen X, et al. Drug resistance mechanisms of mycoplasma pneumoniae to macrolide antibiotics. Biomed Res Int. 2014;2014:320801.PubMedPubMedCentral Liu X, Jiang Y, Chen X, et al. Drug resistance mechanisms of mycoplasma pneumoniae to macrolide antibiotics. Biomed Res Int. 2014;2014:320801.PubMedPubMedCentral
26.
go back to reference Zibo Z, Xiangzhi L, Xiaojian C, et al. Macrolide-resistant mycoplasma pneumoniae in adults in Zhejiang, China. Antimicrob Agents Chemother. 2015;59:1048–51.CrossRef Zibo Z, Xiangzhi L, Xiaojian C, et al. Macrolide-resistant mycoplasma pneumoniae in adults in Zhejiang, China. Antimicrob Agents Chemother. 2015;59:1048–51.CrossRef
27.
go back to reference Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521–3.CrossRef Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521–3.CrossRef
28.
go back to reference Amy ER, Lynn BD, Ken BW. Comparison of the illumigene mycoplasma DNA amplification assay and culture for detection of mycoplasma pneumonia. J Clin Microbiol. 2014;52:1060–3.CrossRef Amy ER, Lynn BD, Ken BW. Comparison of the illumigene mycoplasma DNA amplification assay and culture for detection of mycoplasma pneumonia. J Clin Microbiol. 2014;52:1060–3.CrossRef
29.
go back to reference Wei L, You-Hong F, Hong-Qiang S, et al. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of mycoplasma pneumoniae infection in children with pneumonia. PLoS One. 2017;12:e0177842.CrossRef Wei L, You-Hong F, Hong-Qiang S, et al. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of mycoplasma pneumoniae infection in children with pneumonia. PLoS One. 2017;12:e0177842.CrossRef
30.
go back to reference Wang L, Feng Z, Zhao M, et al. A comparison study between GeXp-based multiplex-PCR and serology assay for mycoplasma pneumoniae detection on children with community acquired pneumonia. BMC Infect Dis. 2017;17:518.CrossRef Wang L, Feng Z, Zhao M, et al. A comparison study between GeXp-based multiplex-PCR and serology assay for mycoplasma pneumoniae detection on children with community acquired pneumonia. BMC Infect Dis. 2017;17:518.CrossRef
31.
go back to reference Liao C, Zhao Y, Wang L. Establishment and validation of RNA-based predictive models for understanding survival of vibrio parahaemolyticus in oysters stored at low temperatures. Appl Environ Microbiol. 2017;83:e02765–16.PubMedPubMedCentral Liao C, Zhao Y, Wang L. Establishment and validation of RNA-based predictive models for understanding survival of vibrio parahaemolyticus in oysters stored at low temperatures. Appl Environ Microbiol. 2017;83:e02765–16.PubMedPubMedCentral
32.
go back to reference Jieqiong L, Lin S, Xirong W, et al. Early diagnosis of mycoplasma pneumoniae in children: simultaneous amplification and testing (SAT) is the key. Front Pediatr. 2019;7:441.CrossRef Jieqiong L, Lin S, Xirong W, et al. Early diagnosis of mycoplasma pneumoniae in children: simultaneous amplification and testing (SAT) is the key. Front Pediatr. 2019;7:441.CrossRef
33.
go back to reference Raty R, Ronkko E, Kleemola M. Sample type is crucial to the diagnosis of mycoplasma pneumoniae pneumonia by PCR. J Med Microbiol. 2005;54:287–91.CrossRef Raty R, Ronkko E, Kleemola M. Sample type is crucial to the diagnosis of mycoplasma pneumoniae pneumonia by PCR. J Med Microbiol. 2005;54:287–91.CrossRef
34.
go back to reference Qu J, Gu L, Wu J, et al. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis. 2013;13:172.CrossRef Qu J, Gu L, Wu J, et al. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis. 2013;13:172.CrossRef
35.
go back to reference Surinder K. Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018;147:23–31.CrossRef Surinder K. Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018;147:23–31.CrossRef
36.
go back to reference Lei Z, Zhi-Yong Z, Yan-Bin L, et al. PCR versus serology for diagnosing mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res. 2011;134:270–80. Lei Z, Zhi-Yong Z, Yan-Bin L, et al. PCR versus serology for diagnosing mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res. 2011;134:270–80.
37.
go back to reference Xiao-yan H, Xing-bin W, Rong Z, et al. Investigation of mycoplasma pneumoniae infection in pediatric population from 12,025 cases with respiratory infection. Diagn Microbiol Infect Dis. 2013;75:22–7.CrossRef Xiao-yan H, Xing-bin W, Rong Z, et al. Investigation of mycoplasma pneumoniae infection in pediatric population from 12,025 cases with respiratory infection. Diagn Microbiol Infect Dis. 2013;75:22–7.CrossRef
38.
go back to reference Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.CrossRef Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.CrossRef
39.
go back to reference Loens K, Ieven M. Mycoplasma pneumoniae: current knowledge on nucleic acid amplification techniques and serological diagnostics. Front Microbiol. 2016;7:448.CrossRef Loens K, Ieven M. Mycoplasma pneumoniae: current knowledge on nucleic acid amplification techniques and serological diagnostics. Front Microbiol. 2016;7:448.CrossRef
Metadata
Title
Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia
Authors
Mingyu Tang
Dong Wang
Xing Tong
Yufen Wu
Jing Zhang
Lei Zhang
Yong Yin
Qing Cao
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2021
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-021-02523-4

Other articles of this Issue 1/2021

BMC Pediatrics 1/2021 Go to the issue